289 related articles for article (PubMed ID: 2894407)
1. Effects of systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mice on tyrosine hydroxylase, L-3,4-dihydroxyphenylalanine decarboxylase, dopamine beta-hydroxylase, and monoamine oxidase activities in the striatum and hypothalamus.
Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu T
J Neurochem; 1988 Apr; 50(4):1053-6. PubMed ID: 2894407
[TBL] [Abstract][Full Text] [Related]
2. Effects of repeated systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase activity in vitro and tyrosine hydroxylase content.
Mogi M; Harada M; Kojima K; Kiuchi K; Nagatsu I; Nagatsu T
Neurosci Lett; 1987 Sep; 80(2):213-8. PubMed ID: 2891089
[TBL] [Abstract][Full Text] [Related]
3. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
Kozina EA; Kim AR; Kurina AY; Ugrumov MV
Neurobiol Dis; 2017 Feb; 98():108-121. PubMed ID: 27940203
[TBL] [Abstract][Full Text] [Related]
4. L-Dihydroxyphenylalanine modulates the steady-state expression of mouse striatal tyrosine hydroxylase, aromatic L-amino acid decarboxylase, dopamine and its metabolites in an MPTP mouse model of Parkinson's disease.
King JM; Muthian G; Mackey V; Smith M; Charlton C
Life Sci; 2011 Oct; 89(17-18):638-43. PubMed ID: 21871902
[TBL] [Abstract][Full Text] [Related]
5. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration to C57-black mice leads to parallel decrements in neostriatal dopamine content and tyrosine hydroxylase activity.
Mayer RA; Walters AS; Heikkila RE
Eur J Pharmacol; 1986 Jan; 120(3):375-7. PubMed ID: 2868908
[TBL] [Abstract][Full Text] [Related]
6. Reversible changes in the accumulation and activities of tyrosine hydroxylase and dopamine-beta-hydroxylase in neurons of nucleus locus coeruleus during the retrograde reaction.
Ross RA; Joh TH; Reis DJ
Brain Res; 1975 Jul; 92(1):57-72. PubMed ID: 240484
[TBL] [Abstract][Full Text] [Related]
7. Phenylethanolamine N-methyltransferase and other enzymes of catecholamine metabolism in human brain.
Nagatsu T; Kato T; Numata Y; Ikuta K; Sano M
Clin Chim Acta; 1977 Mar; 75(2):221-32. PubMed ID: 14798
[TBL] [Abstract][Full Text] [Related]
8. Regulation of tyrosine hydroxylase and aromatic L-amino acid decarboxylase by dopaminergic drugs.
Cho S; Neff NH; Hadjiconstantinou M
Eur J Pharmacol; 1997 Apr; 323(2-3):149-57. PubMed ID: 9128833
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
Fuller RW; Robertson DW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
[TBL] [Abstract][Full Text] [Related]
10. Different toxicity of N-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) on the nigrostriatal and mesolimbic pathways.
Ambrosio S; Gerli P; Perego C; Algeri S
Eur J Pharmacol; 1987 Jan; 133(2):239-41. PubMed ID: 2880741
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment.
Johannessen JN; Chiueh CC; Bacon JP; Garrick NA; Burns RS; Weise VK; Kopin IJ; Parisi JE; Markey SP
J Neurochem; 1989 Aug; 53(2):582-9. PubMed ID: 2568405
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Youngster SK; Sonsalla PK; Heikkila RE
J Neurochem; 1987 Mar; 48(3):929-34. PubMed ID: 3492590
[TBL] [Abstract][Full Text] [Related]
13. Appearance of tyrosine hydroxylase, aromatic amino-acid decarboxylase, dopamine beta-hydroxylase and phenylethanolamine N-methyltransferase during the ontogenesis of the adrenal medulla: an immunohistochemical study in the rat.
Verhofstad AA; Hökfelt T; Goldstein M; Steinbusch HW; Joosten HW
Cell Tissue Res; 1979 Aug; 200(1):1-13. PubMed ID: 40700
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of MPTP-induced dopaminergic neurotoxicity by TV3326, a cholinesterase-monoamine oxidase inhibitor.
Sagi Y; Weinstock M; Youdim MB
J Neurochem; 2003 Jul; 86(2):290-7. PubMed ID: 12871570
[TBL] [Abstract][Full Text] [Related]
15. Histochemical localization of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine oxidation in the mouse brain.
Vincent SR
Neuroscience; 1989; 28(1):189-99. PubMed ID: 2569695
[TBL] [Abstract][Full Text] [Related]
16. Strain differences in systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity in mice correlate best with monoamine oxidase activity at the blood-brain barrier.
Riachi NJ; Harik SI
Life Sci; 1988; 42(23):2359-63. PubMed ID: 3259663
[TBL] [Abstract][Full Text] [Related]
17. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat.
Matsuda LA; Schmidt CJ; Hanson GR; Gibb JW
Neuropharmacology; 1986 Mar; 25(3):249-55. PubMed ID: 2871513
[TBL] [Abstract][Full Text] [Related]
18. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
19. Prevention of dopaminergic toxicity of MPTP in mice by phenylethylamine, a specific substrate of type B monoamine oxidase.
Melamed E; Youdim MB
Br J Pharmacol; 1985 Nov; 86(3):529-31. PubMed ID: 3877535
[TBL] [Abstract][Full Text] [Related]
20. Apomorphine protects against MPTP-induced neurotoxicity in mice.
Grünblatt E; Mandel S; Berkuzki T; Youdim MB
Mov Disord; 1999 Jul; 14(4):612-8. PubMed ID: 10435498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
